NURECA

₹225.35 -1.08 (-0.48%)

24 Mar, 2025 19:26

SIP TrendupStart SIP in NURECA

Start SIP

Performance

  • Low
  • ₹225
  • High
  • ₹231
  • 52 Week Low
  • ₹214
  • 52 Week High
  • ₹448
  • Open Price₹230
  • Previous Close₹226
  • Volume26,711

Investment Returns

  • Over 1 Month -16.46%
  • Over 3 Month -19.06%
  • Over 6 Month -40.77%
  • Over 1 Year -23.32%
SIP Lightning

Smart Investing Starts Here Start SIP with Nureca for Steady Growth!

Invest Now

Nureca Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • -39.1
  • PEG Ratio
  • 0
  • Market Cap Cr
  • 225
  • P/B Ratio
  • 1.2
  • Average True Range
  • 11.54
  • EPS
  • 0
  • Dividend Yield
  • 0
  • MACD Signal
  • -16.04
  • RSI
  • 35.7
  • MFI
  • 42.99

Nureca Financials

Nureca Technicals

EMA & SMA

Current Price
₹225.35
-1.08 (-0.48%)
pointer
  • stock-down_img
  • Bearish Moving Average 16
  • stock-up_img
  • Bullish Moving Average 0
  • 20 Day
  • ₹239.06
  • 50 Day
  • ₹264.21
  • 100 Day
  • ₹280.52
  • 200 Day
  • ₹295.15

Resistance and Support

227.08 Pivot Speed
  • R3 235.07
  • R2 232.98
  • R1 229.17
  • S1 223.27
  • S2 221.18
  • S3 217.37

What's your outlook on Nureca?

You can only vote for once

Ratings

Master Rating

EPS Strenth

Price Strength

Buyer Demand

Group Rank

Nureca has an operating revenue of Rs. 94.89 Cr. on a trailing 12-month basis. An annual revenue de-growth of -14% needs improvement, Pre-tax margin of -3% needs improvement, ROE of -0% is poor and needs improvement. The company is debt free and has a strong balance sheet enabling it to report stable earnings growth across business cycles. The stock from a technical standpoint is trading below to its key moving averages. It needs to take out these levels and stay above it to make any meaningful move. From an O'Neil Methodology perspective, the stock has an EPS Rank of 6 which is a POOR score indicating inconsistency in earnings, a RS Rating of 28 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at C- which is evident from recent supply seen, Group Rank of 64 indicates it belongs to a poor industry group of Medical-Products and a Master Score of D is close to being the worst. Overall, the stock has poor technical strength and poor fundamentals, there are superior stocks in the current market environment.

Disclaimer: This stock analysis report is algorithmically generated for informational purposes only and should not be considered as a buy or sell recommendation.

View More

Nureca Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2025-01-24 Quarterly Results
2024-10-24 Quarterly Results
2024-08-05 Quarterly Results
2024-05-15 Audited Results
2024-02-07 Quarterly Results
Date Purpose Remarks
2022-02-25 INTERIM Rs.3.00 per share(30%)Interim Dividend
View More

Nureca F&O

Nureca Shareholding Pattern

About Nureca

  • NSE Symbol
  • NURECA
  • BSE Symbol
  • 543264
  • ISIN
  • INE0DSF01015

Similar Stocks to Nureca

Nureca FAQs

Nureca share price is ₹225 As on 24 March, 2025 | 19:12

The Market Cap of Nureca is ₹225.4 Cr As on 24 March, 2025 | 19:12

The P/E ratio of Nureca is -39.1 As on 24 March, 2025 | 19:12

The PB ratio of Nureca is 1.2 As on 24 March, 2025 | 19:12

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23